Download PDF
Fortschr Neurol Psychiatr 2009; 77(7): 399-406
DOI: 10.1055/s-0028-1109454
Übersicht

© Georg Thieme Verlag KG Stuttgart · New York

Depressive Störungen bei Demenzen und milder kognitiver Beeinträchtigung: Komorbidität, Ursache oder Risikofaktor?

Depressive Disorders in Dementia and Mild Cognitive Impairments: Is Comorbidity a Cause or a Risk Factor?U. W. Preuss1 , N. Siafarikas1 , M. Petrucci1 , W. M. Wong1
  • 1Klinik für Psychiatrie, Psychotherapie und Psychosomatik der Martin-Luther-Universität Halle-Wittenberg
Further Information

Publication History

Publication Date:
16 June 2009 (online)

    Permissions and Reprints

Zusammenfassung

Depressive Störungen und demenzielle Erkrankungen treten ab dem 65. Lebensjahr einzeln und zusammen gehäuft auf. Ziel dieser Übersicht ist es, anhand einer systematischen Literaturrecherche eine Reihe von Hypothesen zu diskutieren, die dieses überzufällig häufige, gemeinsame Auftreten erklären sollen. Eine Anzahl von Untersuchungen weist auf biologische Gemeinsamkeiten zwischen Depression und Demenz hin, ohne dass diese in allen Studien untermauert werden können. Die Vorgeschichte einer Depression kann als distaler Risikofaktor für demenzielle Erkrankungen angesehen werden. Besonders nach Ausbruch demenzieller Erkrankungen sind depressive Störungen häufig und der Zusammenhang zwischen beiden wahrscheinlich am stärksten. Bei Patienten mit großer kognitiver Reserve kann eine Depression als Reaktion auf die Wahrnehmung der beginnenden kognitiven Defizite gedeutet werden. Sicherlich können Depressionen bei der Alzheimer-Demenz und anderen Demenzformen als eigene Krankheitsentität angesehen werden, zumal sich die klinischen Syndrome von denen anderer Depressionen in früheren Lebensabschnitten etwas unterscheiden. Studien über die Therapie von Depressionen bei Demenzen haben in den letzten Jahren ein steigendes Interesse gefunden. Dabei müssen jedoch bei der Behandlung älterer Patienten mit Antidepressiva einige Regeln beachtet werden, besonders kardiologische und vegetative Nebenwirkungen.

Abstract

Both depression and dementia occur by themselves or together in elderly subjects aged 65 and above. The aim of this review is to discuss several hypotheses which try to explain the frequent co-occurrence exceeding chance alone, based on a systematic literature search. A series of studies revealed potential biological similarities between both disorders which, however, were not found in all investigations. Lifetime history of depression can be considered as a distant risk factor for dementias. Depression occurs most frequently within one year before and after the onset of dementia, in which the association between both disorders is probably strongest. In a subgroup of subjects with more ”cognitive reserve”, depression was found to be a consequence of patient’s realisation of beginning cognitive deficits. Several studies indicate that depression in Alzheimer and other dementia forms can be considered as a separate disease entity, as the clinical syndrome differs from depression in earlier periods of life. Studies on the therapy of depression in dementia have aroused increasing interest in recent years. Herewith, certain guidelines in the treatment of older patients with antidepressants must be followed.

Schlüsselwörter

depressive Störungen - Demenz vom Alzheimer-Typ - vaskuläre Demenz - milde kognitive Beeinträchtigung

Key words

depressive disorder - Alzheimer dementia - vascular dementia - mild cognitive impairment

Literatur

  • 1 Amore M, Tagariello P, Laterza C. et al . Subtypes of depression in dementia.  Arch Gerontol Geriatr. 2007;  44 (Suppl 1) 23-33
    Google Scholar
  • 2 Starkstein S E, Mizrahi R. Depression in Alzheimer’s disease.  Expert Rev Neurother. 2006;  6 887-895
    Google Scholar
  • 3 Ellison J M, Harper D G, Berlow Y. et al . Beyond the ”C” in MCI: noncognitive symptoms in amnestic and non-amnestic mild cognitive impairment.  CNS Spectr. 2008;  13 66-72
    Google Scholar
  • 4 Lyketsos C G, Lopez O, Jones B. et al . Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the Cardiovascular Health Study.  JAMA. 2002;  288 1475-1483
    Google Scholar
  • 5 Lyketsos C G, Steinberg M, Tschanz J T. et al . Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging.  Amercian Journal of Psychiatry. 2000;  157 708-714
    Google Scholar
  • 6 Visser P J, Verhey F RJ, Ponds R WHM. et al . Distinction between preclinical Alzheimer’s disease and depression.  J Am Geriatr Soc. 2000;  48 479-484
    Google Scholar
  • 7 Cho M J, Lyoo I K, Lee D W. et al . Brain single photon emission computed tomography findings in depressive pseudodementia patients.  J Affect Disord. 2002;  69 159-166
    Google Scholar
  • 8 Chen P, Ganguli M, Mulsant B H. et al . The temporal relationship between depressive symptoms and dementia: a community-based prospective study.  Arch Gen Psychiatry. 1999;  56 261-266
    Google Scholar
  • 9 Ganguli M, Du Y, Dodge H H. et al . Depressive symptoms and cognitive decline in late life: a prospective epidemiological study.  Arch Gen Psychiatry. 2006;  63 153-160
    Google Scholar
  • 10 Mitchell A J. Depression as a risk factor for later dementia: a robust relationship?.  Age Ageing. 2005;  34 (3) 207-209
    Google Scholar
  • 11 Jorm A F. Is depression a risk factor for dementia or cognitive decline? A review.  Gerontology. 2000;  46 219-227
    Google Scholar
  • 12 Jorm A F. History of depression as a risk factor for dementia: an updated review.  Aust N Z J Psychiatry. 2001;  35 776-781
    Google Scholar
  • 13 Jorm A F. The epidemiology of depressive states in the elderly: Implications for recognition, intervention and prevention.  Soc Psychiatry Psychiatr Epidemiol. 1995;  30 53-59
    Google Scholar
  • 14 Gorelick P B. Status of risk factors for dementia associated with stroke.  Stroke. 1997;  28 459-463
    Google Scholar
  • 15 Wittchen H U, Pfister H, Schmidtkunz B. et al .Zusatzsurvey „Psychische Störungen” (Bundesgesundheitssurvey 98): Häufigkeit, psychosoziale Beeinträchtigungen und Zusammenhänge mit körperlichen Erkrankungen. Anlagen (Anlagen zum Schlussbericht BMBFBW 01 EH 9701 / 8). München; Max-Planck-Institut für Psychiatrie, Klinische Psychologie und Epidemiologie 2000
    Google Scholar
  • 16 McCusker J, Cole M, Dufouil C. et al . The prevalence and correlates of major and minor depression in older medical inpatients.  J Am Geriatr Soc. 2005;  53 1344-1353
    Google Scholar
  • 17 Burvill P, Johnson G, Jamrozik K. et al . Risk factors for poststroke depression.  Int J Geriatr Psychiatry. 1997;  12 219-226
    Google Scholar
  • 18 Kato T. Molecular genetics of bipolar disorder and depression.  Psychiatry Clin Neurosci. 2007;  61 3-19
    Google Scholar
  • 19 Turner R S. Alzheimer’s disease.  Semin Neurol. 2006;  26 499-450
    Google Scholar
  • 20 Fahim S, Duijn C M, Baker F M. et al . A study of familial aggregation of depression, dementia and Parkinson’s disease.  Eur J Epidemiol. 1998;  14 233-238
    Google Scholar
  • 21 The Canadian study of health and aging: Risk factors for Alzheimer’s disease in Canada.  Neurology. 1994;  44 2073-2080
    Google Scholar
  • 22 Papassotiropoulos van A, Fountoulakis M, Dunckley T. et al . Genetics, transcriptomics, and proteomics of Alzheimer’s disease.  J Clin Psychiatry. 2006;  67 652-670
    Google Scholar
  • 23 Stoppel C, Bielau H, Bogerts B. et al . Neurobiological basis of depressive disorders.  Fortschr Neurol Psychiatr. 2006;  74 696-705
    Google Scholar
  • 24 Pritchard A L, Harris J, Pritchard C W. et al . Role of 5 HT(2A) and 5 HT(2C) polymorphisms in behavioural and psychological symptoms of Alzheimer’s disease.  Neurobiol Aging. 2008;  29 341-347
    Google Scholar
  • 25 Steffens D C, Plassman B L, Helms M J. et al . A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer’s disease.  Biol Psychiatry. 1997;  41 851-856
    Google Scholar
  • 26 Geda Y E, Knopman D S, Mrazek D A. et al . Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study.  Arch Neurol. 2006;  63 435-440
    Google Scholar
  • 27 Taylor W D, Steffens D C, Krishnan K R. Psychiatric disease in the twenty-first century: The case for subcortical ischemic depression.  Biol Psychiatry. 2006;  60 1299-1303
    Google Scholar
  • 28 Butters M A, Whyte E M, Nebes R D. et al . The nature and determinants of neuropsychological functioning in late-life depression.  Arch Gen Psychiatry. 2004;  61 587-595
    Google Scholar
  • 29 Dufouil C, Kersaint-Gilly de A, Besancon V. et al . Longitudinal study of blood pressure and white matter hyperintensities.  Neurology. 2001;  56 921-926
    Google Scholar
  • 30 Iosifescu D V, Papakostas G I, Lyoo I K. et al . Brain MRI hyperintensities and one-carbon cycle metabolism in non-geriatric outpatients with major depressive disorder (Part I).  Psychiatry Res. 2005;  140 291-299
    Google Scholar
  • 31 Barnes D E, Alexopoulos G S, Lopez O L. et al . Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.  Arch Gen Psychiatry. 2006;  63 273-279
    Google Scholar
  • 32 Modrego P J, Ferrandez J. Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study.  Arch Neurol. 2004;  61 1290-1293
    Google Scholar
  • 33 Valenzuela M J, Sachdev P. Brain reserve and cognitive decline: a non-parametric systematic review.  Psychol Med. 2006;  36 1065-1073
    Google Scholar
  • 34 Schofield P. Alzheimer’s disease and brain reserve.  Aust J Ageing. 1999;  18 10-14
    Google Scholar
  • 35 Spitznagel M B, Tremont G, Brown L B. et al . Cognitive reserve and the relationship between depressive symptoms and awareness of deficits in dementia.  J Neuropsychiatry Clin Neurosci. 2006;  18 186-190
    Google Scholar
  • 36 Geerlings M I, Schoevers R A, Beekman A T. et al . Depression and risk of cognitive decline and Alzheimer’s disease. Results of two prospective community-based studies in The Netherlands.  Br J Psychiatry. 2000;  176 568-575
    Google Scholar
  • 37 Baker S C, Frith C D, Dolan R J. The interaction between mood and cognitive function studies with PET.  Psychological Medicine. 1997;  27 565-578
    Google Scholar
  • 38 Sapolsky R M. Glucocorticoids and hippocampal atrophy in neuropsychiatry disorders.  Arch Gen Psychiatry. 2000;  57 925-935
    Google Scholar
  • 39 Meeks T W, Ropacki S A, Jeste D V. The neurobiology of neuropsychiatric syndromes in dementia.  Curr Opin Psychiatry. 2006;  19 581-586
    Google Scholar
  • 40 Sapolsky R M. Stress, the Aging Brain, and the Mechanisms of Neuron Death. Cambridge; MIT Press 1992
    Google Scholar
  • 41 Dwivedi Y, Rizavi H S, Conley R R. et al . Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects.  Arch Gen Psychiatry. 2003;  60 804-815
    Google Scholar
  • 42 Green R C, Cupples L A, Kurz A. et al . Depression as a risk factor for Alzheimer disease: The MIRAGE study.  Arch Neurol. 2003;  60 753-759
    Google Scholar
  • 43 Frodl T, Schaub A, Banac S. et al . Reduced hippocampal volume correlates with executive dysfunctioning in major depression.  J Psychiatry Neurosci. 2006;  31 316-323
    Google Scholar
  • 44 Campbell S, Marriott M, Nahmias C. et al . Lower hippocampal volume in patients suffering from depression: a meta-analysis.  Am J Psychiatry. 2004;  161 598-607
    Google Scholar
  • 45 Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies.  Am J Psychiatry. 2004;  161 1957-1966
    Google Scholar
  • 46 Colla M, Kronenberg G, Deuschle M. et al . Hippocampal volume reduction and HPA-system activity in major depression.  J Psychiatr Res. 2007;  41 553-560
    Google Scholar
  • 47 Magri F, Cravello L, Barili L. et al . Stress and dementia: the role of the hypothalamicpituitary-adrenal axis.  Aging Clin Exp Res. 2006;  18 167-170
    Google Scholar
  • 48 Holsboer F. Corticotropin-releasing hormone modulators and depression.  Curr Opin Investig Drugs. 2003;  4 46-50
    Google Scholar
  • 49 Frodl T, Meisenzahl E M, Zetzsche T. et al . Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up.  J Clin Psychiatry. 2004;  65 492-499
    Google Scholar
  • 50 Swann A, O’Brien J, Ames D. et al . Does hippocampal atrophy on MRI predict cognitive decline? A prospective follow-up study.  Int J Geriatr Psychiatry. 1997;  12 1182-1188
    Google Scholar
  • 51 Rapp M A, Schnaider-Beeri M, Grossman H T. et al . Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression.  Arch Gen Psychiatry. 2006;  63 161-167
    Google Scholar
  • 52 Zubenko G S, Moossy J, Kopp U. Neurochemical correlates of major depression in primary dementia.  Arch Neurol. 1990;  47 209-214
    Google Scholar
  • 53 Yaffe K, Blackwell T, Gore R. et al . Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study.  Arch Gen Psychiatry. 1999;  56 425-430
    Google Scholar
  • 54 Starkstein S E, Sabe L, Vazquez S. et al . Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer’s disease.  Stroke. 1996;  27 408-414
    Google Scholar
  • 55 Mayberg H S. Clinical correlates of PET- and SPECT-identified defects in dementia.  J Clin Psychiatry. 1994;  55 Suppl 12-21
    Google Scholar
  • 56 Brodaty H, Luscombe G, Anstey K J. et al . Neuropsychological performance and dementia in depressed patients after 25-year follow-up: a controlled study.  Psychol Med. 2003;  33 1263-1275
    Google Scholar
  • 57 Wilson R S, Evans D A, Bienias J L. et al . Proneness to psychological distress is associated with risk of Alzheimer’s disease.  Neurology. 2003;  61 1479-1485
    Google Scholar
  • 58 Jorm A F, Duijn C M, Chandra van V. et al . Psychiatric history and related exposures as risk factors for Alzheimer’s disease: A collaborative reanalysis of case-control studies.  Int J Epidemiol. 1991;  20 S43-S47
    Google Scholar
  • 59 Lopez O L, Becker J T, Sweet R A. et al . Psychiatric symptoms vary with the severity of dementia in probable Alzheimer’s disease.  J Neuropsychiatry Clin Neurosci. 2003;  15 346-353
    Google Scholar
  • 60 Lopez O L, Jagust W J, Dulberg C. et al . Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2.  Arch Neurol. 2003;  60 1394-1399
    Google Scholar
  • 61 Berger A K, Fratiglioni L, Forsell Y. et al . The occurrence of depressive symptoms in the preclinical phase of AD: a population based study.  Neurology. 1999;  53 1998-2002
    Google Scholar
  • 62 Wilson R S, Barnes L L, Mendes de Leon C F. et al . Depressive symptoms, cognitive decline, and risk of AD in older persons.  Neurology. 2002;  59 364-370
    Google Scholar
  • 63 Jost B C, Grossberg G T. The evolution of psychiatric symptoms in Alzheimer’s disease: a natural history study.  J Am Geriatr Soc. 1996;  44 1078-1081
    Google Scholar
  • 64 O’Brien J, Desmond P, Ames D. et al . A magnetic resonance imaging study of white matter lesions in depression and Alzheimer’s disease.  Br J Psychiatry. 1996;  168 477-485
    Google Scholar
  • 65 Hofman M, Seifritz E, Krauchi K. et al . Alzheimer’s disease, depression and normal ageing: merit of simple psychomotor and visuospatial tasks.  Int J Geriatr Psychiatry. 2000;  15 31-39
    Google Scholar
  • 66 Fuhrer R, Dufouil C, Dartigues J F. Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study.  J Am Geriatr Soc. 2003;  51 1055-1063
    Google Scholar
  • 67 Cervilla J A, Prince M, Joels S. et al . Does depression predict cognitive outcome 9 to 12 years later? Evidence from a prospective study of elderly hypertensives.  Psychol Med. 2000;  30 1017-1023
    Google Scholar
  • 68 Paterniti S, Dufouil C, Alperovitch A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study.  J Clin Psychopharmacol. 2002;  22 285-293
    Google Scholar
  • 69 Alexopoulos G S, Meyers B S, Young R C. et al . The course of geriatric depression with ”reversible dementia”: a controlled study.  Am J Psychiatry. 1993;  150 1693-1699
    Google Scholar
  • 70 Wilson R S, Arnold S E, Beck T L. et al . Change in depressive symptoms during the prodromal phase of Alzheimer disease.  Arch Gen Psychiatry. 2008;  65 439-445
    Google Scholar
  • 71 Chen P, Ganguli M, Mulsant B H. et al . The temporal relationship between depressive symptoms and dementia: a community-based prospective study.  Arch Gen Psychiatry. 1999;  56 261-266
    Google Scholar
  • 72 Devanand D P, Sano M, Tang M X. et al . Depressed mood and the incidence of Alzheimer’s disease in the elderly living in the community.  Arch Gen Psychiatry. 1996;  53 175-182
    Google Scholar
  • 73 Bickel H, Cooper B. Incidence and relative risk of dementia in an urban elderly population: findings of a prospective field study.  Psychol Med. 1994;  24 179-192
    Google Scholar
  • 74 Dufouil C, Fuhrer R, Dartigues J F. et al . Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration.  Am J Epidemiol. 1996;  144 634-641
    Google Scholar
  • 75 Henderson A S, Korten A E, Jacomb P A. et al . The course of depression in the elderly: a longitudinal community-based study in Australia.  Psychol Med. 1997;  27 119-129
    Google Scholar
  • 76 Zubenko G S, Zubenko W N, McPherson S. et al . A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer’s disease.  Am J Psychiatry. 2003;  160 857-866
    Google Scholar
  • 77 Kurz A. ”BPSSD”: behavioral disorders in dementia. A new diagnostic and therapeutic concept?.  Nervenarzt. 1998;  69 269-273
    Google Scholar
  • 78 Franco K N, Messinger-Rapport B. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.  J Am Med Dir Assoc. 2006;  7 201-202
    Google Scholar
  • 79 Snowden M, Steinman L, Frederick J. Treating depression in older adults: challenges to implementing the recommendations of an expert panel.  Prev Chronic Dis. 2008;  5 A26
    Google Scholar
  • 80 Sink K M, Holden K F, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence.  JAMA. 2005;  293 596-608
    Google Scholar
  • 81 Lyketsos C G, DelCampo L, Steinberg M. et al . Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.  Arch Gen Psychiatry. 2003;  60 737-746
    Google Scholar
  • 82 Mitchell A J, Subramaniam H. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies.  Am J Psychiatry. 2005;  162 1588-1601
    Google Scholar
  • 83 Brodaty H, Green A, Koschera A. Meta-analysis of psychosocial interventions for caregivers of people with dementia.  J Am Geriatr Soc. 2003;  51 657-664
    Google Scholar
  • 84 Erkinjuntti T, Kurz A, Gauthier S. et al . Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial.  Lancet. 2002;  359 1283-1290
    Google Scholar
  • 85 Teri L, Logsdon R G, Uomoto J. et al . Behavioral treatment of depression in dementia patients: a controlled clinical trial.  Journal of Gerontology (Series B, Psychological Sciences and Social Sciences). 1997;  52 P159-P166
    Google Scholar

PD Dr. med. Ulrich W. Preuss

Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Martin-Luther-Universität Halle-Wittenberg

Julius-Kühn-Straße 7

06097 Halle/Saale

Email: ulrich.preuss@medizin.uni-halle.de

      >